“We are pleased to broaden our AbbVie collaboration and look forward to using AbCellera’s TCE platform to bring novel cancer immunotherapies to patients in need,” said Carl Hansen, Ph.D., founder and ...
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/100.sbqKNnJW.js ...
VANCOUVER, British Columbia, January 13, 2025--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) announced today that it has expanded its existing collaboration with AbbVie Inc. (NYSE: ABBV) to include ...
“We are pleased to broaden our AbbVie collaboration and look forward to using AbCellera’s TCE platform to bring novel cancer immunotherapies to patients in need,” said Carl Hansen, Ph.D ...
AbCellera announced that it has expanded its existing collaboration with AbbVie Inc. to include the discovery of T-cell ...
Inquiries Media: Tiffany Chiu; [email protected], +1(236)521-6774 Partnering: Murray McCutcheon, Ph.D.; [email protected], +1(604)559-9005 Investor Relations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback